Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease chronic lymphocytic leukemia
Symptom C0009450|infection
Sentences 12
PubMedID- 23607863 Secondary hypogammaglobulinemia is one of the factors responsible for the increased susceptibility to infection in patients with chronic lymphocytic leukemia (cll).
PubMedID- 21946761 The unusual histopathological and phenotypic findings described in this case of cutaneous manifestations of b-cell chronic lymphocytic leukemia associated with borrelia burgdorferi infection may lead to the misdiagnosis of cutaneous marginal zone b-cell lymphoma.
PubMedID- 25115508 Late reactivation of occult hepatitis b virus infection in a patient with chronic lymphocytic leukemia after rituximab and fludarabine-based regimen.
PubMedID- 25687054 Elderly chronic lymphocytic leukemia combined with invasive aspergillosis infection in one case.
PubMedID- 22774920 Immunoglobulin g (igg) preparations are approved by the us food and drug administration for the treatment of primary immunodeficiency disease, idiopathic thrombocytopenic purpura, kawasaki disease, chronic lymphocytic leukemia with frequent infections, bone marrow transplantation, to prevent infection in pediatric human immunodeficiency virus, and chronic inflammatory demyelinating polyneuropathy.
PubMedID- 21991346 Recently, an association of mcpyv infection with chronic lymphocytic leukemia (cll) was reported –, yet the causal association remains to be proven.
PubMedID- 21959050 Considering the successful combined modality of immunosuppressive therapy with csa and pdn-based regimens in preventing acute rejection in organ transplantation and the effect of intravenous immunoglobulin on preventing infections in patients with chronic lymphocytic leukemia, we postulated that patients who have failed first-line chop (cyclophosphamide, doxorubicin, vincristine, and pdn) or chop-like regimens might benefit from long-term treatment with a combination of csa, pdn, and a monthly high-dose intravenous immunoglobulin (hdivig), which may help reduce the risk of infection during therapy.
PubMedID- 22567080 In the category of infectious diseases, the leading scenario was prevention of infection in a patient with chronic lymphocytic leukemia who had low levels of igg but no history of serious infection.
PubMedID- 21724431 Hemophagocytic lymphohistiocytosis associated with influenza a (h1n1) infection in a patient with chronic lymphocytic leukemia: an autopsy case report and review of the literature.
PubMedID- 25682966 Prevalence, characteristics and management of occult hepatitis b virus infection in patients with chronic lymphocytic leukemia: a single center experience.
PubMedID- 24270260 Aureobasidium pullulans infection in a patient with chronic lymphocytic leukemia.
PubMedID- 22266154 A randomized, controlled trial of panax quinquefolius extract (cvt-e002) to reduce respiratory infection in patients with chronic lymphocytic leukemia.

Page: 1